PE20000727A1 - Compuestos de tetrahidronaftiridinil-carboxamida - Google Patents

Compuestos de tetrahidronaftiridinil-carboxamida

Info

Publication number
PE20000727A1
PE20000727A1 PE1999000519A PE00051999A PE20000727A1 PE 20000727 A1 PE20000727 A1 PE 20000727A1 PE 1999000519 A PE1999000519 A PE 1999000519A PE 00051999 A PE00051999 A PE 00051999A PE 20000727 A1 PE20000727 A1 PE 20000727A1
Authority
PE
Peru
Prior art keywords
alkyl
tetrahydronaphthyridinyl
naphthyridin
tetrahydro
trimethyl
Prior art date
Application number
PE1999000519A
Other languages
English (en)
Inventor
Mervyn Thompson
John David Harling
Frank Peter Harrington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PE20000727A1 publication Critical patent/PE20000727A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A COMPUESTOS TETRAHIDRONAFTIRIDINIL-CARBOXAMIDA DE FORMULA I, DONDE R1 ES H, ALQUILO C1-C6 (OPCIONALMENTE SUSTITUIDO CON OH, ALCOXI C1-C4), FENIL-ALQUILO C1-C4, ALQUENILO C1-C6, ALQUINILO C1-C6; R2 ES H, HALOGENO, NO2, CN, CF3O-, CF3S-, CF3SO2, CF3CO, ALQUILO C1-C6, ENTRE OTROS; DOS DE R2 FORMAN UN CARBOCICLO OPCIONALMENTE SUSTITUIDO CON O, NH; R3 Y R4 SON H, ALQUILO C1-C6; DOS DE R3 o R4 FORMAN JUNTOS UN ESPIROALQUILO, CUANDO UNO DE R3 Y R4 NO SEA H; X ES H, HALOGENO, CIANO, ALQUILO, ALCOXI. SON COMPUESTOS PREFERIDOS N-5,6,7,8-TETRAHIDRO-6,8,8-TRIMETIL-[1,6]-NAFTIRIDIN-3-IL)BENZAMIDA; N-5,6,7,8-TETRAHIDRO-6,8,8-TRIMETIL-[1,6]-NAFTIRIDIN-3-IL)4-METOXI-3-TRIFLUOROMETILBENZAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I PUEDE SER UTIL PARA EL TRATAMIENTO DE ANSIEDAD, MANIA, DEPRESION, ATAQUES DE PANICO, AGRESION, EPILEPSIA, MIGRANA, TRASTORNOS ASOCIADOS CON UNA HEMORRAGIA SUBARACNOIDEA O CHOQUE NEURAL
PE1999000519A 1998-06-12 1999-06-11 Compuestos de tetrahidronaftiridinil-carboxamida PE20000727A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9812683.2A GB9812683D0 (en) 1998-06-12 1998-06-12 Novel compounds

Publications (1)

Publication Number Publication Date
PE20000727A1 true PE20000727A1 (es) 2000-09-28

Family

ID=10833636

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000519A PE20000727A1 (es) 1998-06-12 1999-06-11 Compuestos de tetrahidronaftiridinil-carboxamida

Country Status (31)

Country Link
US (2) US6410555B1 (es)
EP (1) EP1084122B1 (es)
JP (1) JP2002518390A (es)
KR (1) KR20010052792A (es)
CN (1) CN1311789A (es)
AP (1) AP2000002009A0 (es)
AR (1) AR018656A1 (es)
AT (1) ATE252579T1 (es)
AU (1) AU750470B2 (es)
BG (1) BG105126A (es)
BR (1) BR9911110A (es)
CA (1) CA2334900A1 (es)
CO (1) CO5040081A1 (es)
CZ (1) CZ293010B6 (es)
DE (1) DE69912278T2 (es)
EA (1) EA200100033A1 (es)
ES (1) ES2209524T3 (es)
GB (1) GB9812683D0 (es)
HU (1) HUP0102773A3 (es)
ID (1) ID27593A (es)
IL (1) IL140171A0 (es)
MA (1) MA26646A1 (es)
NO (1) NO20006269L (es)
NZ (1) NZ508799A (es)
PE (1) PE20000727A1 (es)
PL (1) PL344791A1 (es)
SK (1) SK18962000A3 (es)
TR (1) TR200003694T2 (es)
TW (1) TW495510B (es)
WO (1) WO1999065903A1 (es)
ZA (1) ZA200007397B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds
DE60100055T2 (de) * 2001-03-21 2003-07-24 Sanol Arznei Schwarz Gmbh Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
CA2624625A1 (en) * 2005-11-04 2007-05-10 Pfizer Limited Tetrahydronaphthyridine derivative
JP6378182B2 (ja) * 2012-08-27 2018-08-22 アレイ バイオファーマ、インコーポレイテッド 過剰増殖性│疾患の処置のためのセリン/スレオニンキナーゼ阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
EP0906283A1 (en) 1996-06-17 1999-04-07 Smithkline Beecham Plc Substituted benzamide derivatives and their use as anticonvulsants
GB9711257D0 (en) * 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
NZ508799A (en) 2003-08-29
US6762192B2 (en) 2004-07-13
AR018656A1 (es) 2001-11-28
IL140171A0 (en) 2002-02-10
TR200003694T2 (tr) 2001-06-21
ES2209524T3 (es) 2004-06-16
DE69912278D1 (en) 2003-11-27
EA200100033A1 (ru) 2001-06-25
BG105126A (en) 2001-11-30
NO20006269D0 (no) 2000-12-11
SK18962000A3 (sk) 2001-08-06
EP1084122A1 (en) 2001-03-21
US20020143029A1 (en) 2002-10-03
JP2002518390A (ja) 2002-06-25
ATE252579T1 (de) 2003-11-15
TW495510B (en) 2002-07-21
KR20010052792A (ko) 2001-06-25
AP2000002009A0 (en) 2000-12-31
CZ20004611A3 (en) 2001-06-13
MA26646A1 (fr) 2004-12-20
BR9911110A (pt) 2001-10-30
WO1999065903A1 (en) 1999-12-23
ZA200007397B (en) 2002-02-27
HUP0102773A3 (en) 2002-09-30
NO20006269L (no) 2001-02-07
PL344791A1 (en) 2001-11-19
CO5040081A1 (es) 2001-05-29
AU4280099A (en) 2000-01-05
US6410555B1 (en) 2002-06-25
CA2334900A1 (en) 1999-12-23
HUP0102773A2 (hu) 2002-01-28
EP1084122B1 (en) 2003-10-22
AU750470B2 (en) 2002-07-18
DE69912278T2 (de) 2004-08-12
ID27593A (id) 2001-04-12
CZ293010B6 (cs) 2004-01-14
CN1311789A (zh) 2001-09-05
GB9812683D0 (en) 1998-08-12

Similar Documents

Publication Publication Date Title
NO941052L (no) Benzimidazolforbindelser, deres anvendelse og fremstilling
AR240794A2 (es) Derivados de 2-(2'-nitrobenzoil)-1,3-ciclohexanodiona composicion herbicida que los comprende y procedimiento para prepararlos.
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
ATE277012T1 (de) Piperidin- und pyrrolidin-derivate enthaltend ein stickstoffoxid donor zur behandlung von stress
FI904327A0 (fi) N-substituerad-4-pyrimidinaminer och -pyrimidindiaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
CA2261680A1 (en) Fluorine-containing 1,4-disubstituted piperidine derivatives
PE107999A1 (es) Derivados 3-amidinoanilina, inhibidores del factor x de coagulacion de la sangre activado e intermediarios de los mismos
PE20021002A1 (es) Compuestos heterociclicos condensados
PE86599A1 (es) Inhibidores de la farnesil proteina transferasa
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
ATE229950T1 (de) Chinolin carbonsaure-derivate und ihre salze
PE79599A1 (es) Derivados de 5'-desoxicitidina
PE20000727A1 (es) Compuestos de tetrahidronaftiridinil-carboxamida
ID24846A (id) Turunan-turunan bifenilamidina
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
AR248126A1 (es) Nuevos derivados sustituidos de bicicloheptanodiona, procedimiento para obtenerlos y composiciones herbicidas que los contienen.
PE60096A1 (es) Inhibidor de la escualeno sintetasa
PE20020411A1 (es) Compuestos derivados de la triptamina y sus analogos que interactuan con el sistema melatoninergico
PE20000006A1 (es) Compuestos de tetrahidroisoquinoleinil-carboxamida
KR950002761A (ko) 강박 반응 장애 치료제 제조용으로서의 n-(피리디닐)-1h-인돌-1-아민의 용도
PE54797A1 (es) Tetralinas
ATE195929T1 (de) Fluorierte alkane und ihre verwendungen
PE62199A1 (es) Derivado de tetrahidro isoquinolinil-benzamida
BR9909029A (pt) Estabilização de poliisocianatos orgânicos
PE20001057A1 (es) Nuevos bis-benzimidazoles

Legal Events

Date Code Title Description
FC Refusal